ARK Genomic Revolution ETF vs Amer Sports Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.19, while Amer Sports Inc trades at $33.4 (market cap $19.69B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Amer Sports Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | AS | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $41.96 |
52-Week Low | $24.02 | $29.54 |
Market Cap | — | $19.69B |
Enterprise Value | — | $20.01B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Amer Sports (AS) trades at $33.67, down 6.91% over 24 hours, with a bearish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $0.38 and revenue growth of 32% year-over-year, and raised full-year guidance. Key financials show a net income margin of 6.5% and positive cash flow from operations of $729.8 million in 2025.
The outlook is supported by analyst consensus with 12 buy ratings and a $58.67 price target, but risks include high valuation multiples like a P/E of 42.3 and competitive pressures in the sports apparel sector. Near-term focus is on Q2 2026 earnings due August 18, 2026, which could drive volatility.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.
Read more on AS →